Biogen

By person

21 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

ALEXANDER SUSAN H

EVP Chief Legal Officer

—

61,889

$12.44M

+19.7%

DORSA CAROLINE

Director

—

31,002

$6.23M

+16.5%

Viehbacher Christopher

President and CEO

—

29,924

$6.01M

+327.5%

Rowinsky Eric K

Director

—

25,844

$5.19M

+17.6%

McDonnell Michael R.

EVP, Chief Financial Officer

—

24,341

$4.89M

+25.4%

Gregory Ginger

EVP, Human Resources

—

22,359

$4.49M

+61.5%

Murphy Nicole

Head of Pharm Ops and Tech

—

19,611

$3.94M

+100.1%

SHERWIN STEPHEN A

Director

—

15,193

$3.05M

−24.3%

Kramer Robin

Chief Financial Officer

—

11,472

$2.31M

+84.2%

Mantas Jesus B

Director

—

11,263

$2.26M

+52.4%

Izzar Rachid

Head of Global Product Strat.

—

11,011

$2.21M

+137.6%

HAWKINS WILLIAM A

Director

—

10,365

$2.08M

+59.7%

Freire Maria C

Director

—

8,820

$1.77M

+98.4%

Singhal Priya

Head of Development

—

8,043

$1.62M

+46.7%

LANGER SUSAN

Director

—

6,634

$1.33M

+140.4%

Keeney Adam

Head of Corporate Development

—

6,365

$1.28M

+861.5%

Patolawala Monish D

Director

—

5,215

$1.05M

+289.2%

Grogan Jane

Head of Research

—

4,058

$815.50K

—

Pangalos Menelas N

Director

—

3,875

$778.72K

—

Minor Lloyd

Director

—

2,689

$540.38K

—

Godbout Sean

Chief Accounting Officer

—

1,342

$269.62K

+181.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

By person

Individual transactions

What was left out